(Q38177181)

30 August 2017

title

Autoantibody-mediated bone loss (English)

1 reference

30 August 2017

1 reference

3

Georg Schett

1 reference

30 August 2017

Ulrike Harre

1

1 reference

30 August 2017

Nicolai A Kittan

series ordinal

2

1 reference

30 August 2017

publication date

1 March 2014

1 reference

Current osteoporosis reports

30 August 2017

published in

1 reference

30 August 2017

volume

12

1 reference

30 August 2017

issue

1

1 reference

30 August 2017

page(s)

17-21

1 reference

Cellular communications in bone homeostasis and repair

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11914-013-0185-9

Osteoprotection by semaphorin 3A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-013-0185-9

The effect of targeted rheumatoid arthritis therapies on anti-citrullinated protein autoantibody levels and B cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-013-0185-9

Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-013-0185-9

Marker antibodies of rheumatoid arthritis: Diagnostic and pathogenetic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-013-0185-9

Profiling of rheumatoid arthritis associated autoantibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-013-0185-9

Biomarkers of good EULAR response to the B cell depletion therapy in all seropositive rheumatoid arthritis patients: clues for the pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-013-0185-9

2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-013-0185-9

A NEW SERUM FACTOR IN PATIENTS WITH RHEUMATOID ARTHRITIS; THE ANTIPERINUCLEAR FACTOR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-013-0185-9

Use and significance of anti-CCP autoantibodies in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-013-0185-9

Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-013-0185-9

Epitope spreading of the anti-citrullinated protein antibody response occurs before disease onset and is associated with the disease course of early arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-013-0185-9

Immunity to citrullinated proteins in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-013-0185-9

Monoclonal IgG antibodies generated from joint-derived B cells of RA patients have a strong bias toward citrullinated autoantigen recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-013-0185-9

PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-013-0185-9

The pathogenesis of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-013-0185-9

A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-013-0185-9

Antibodies against citrullinated vimentin in rheumatoid arthritis: higher sensitivity and extended prognostic value concerning future radiographic progression as compared with antibodies against cyclic citrullinated peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-013-0185-9

Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-013-0185-9

Autoimmunity in rheumatoid arthritis: different antigens--common principles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-013-0185-9

Recognition of citrullinated and carbamylated proteins by human antibodies: specificity, cross-reactivity and the 'AMC-Senshu' method

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-013-0185-9

Citrullinated vimentin as an important antigen in immune complexes from synovial fluid of rheumatoid arthritis patients with antibodies against citrullinated proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-013-0185-9

Circulating immune complexes contain citrullinated fibrinogen in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-013-0185-9

Immune complexes from rheumatoid arthritis synovial fluid induce FcgammaRIIa dependent and rheumatoid factor correlated production of tumour necrosis factor-alpha by peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-013-0185-9

Antibody-mediated modulation of immune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-013-0185-9

Induction of macrophage secretion of tumor necrosis factor alpha through Fcgamma receptor IIa engagement by rheumatoid arthritis-specific autoantibodies to citrullinated proteins complexed with fibrinogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-013-0185-9

Anti-citrullinated protein antibodies bind surface-expressed citrullinated Grp78 on monocyte/macrophages and stimulate tumor necrosis factor alpha production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-013-0185-9

Positive regulators of osteoclastogenesis and bone resorption in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-013-0185-9

Different effects of biological drugs in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-013-0185-9

To switch or not to switch after a poor response to a TNFα blocker? It is not only a matter of ACR20 OR ACR50.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-013-0185-9

Anakinra for rheumatoid arthritis: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-013-0185-9

Bone loss before the clinical onset of rheumatoid arthritis in subjects with anticitrullinated protein antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-013-0185-9

Inflammatory monocytes and Fcγ receptor IV on osteoclasts are critical for bone destruction during inflammatory arthritis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-013-0185-9

Immune complex-induced inhibition of osteoclastogenesis is mediated via activating but not inhibitory Fcγ receptors on myeloid precursor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-013-0185-9

Co-opting endogenous immunoglobulin for the regulation of inflammation and osteoclastogenesis in humans and mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-013-0185-9

Glycan profiling of anti-citrullinated protein antibodies isolated from human serum and synovial fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-013-0185-9

The impact of glycosylation on the biological function and structure of human immunoglobulins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-013-0185-9

Low-avidity anticitrullinated protein antibodies (ACPA) are associated with a higher rate of joint destruction in rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-013-0185-9

B-cell therapies in established rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-013-0185-9

Synovial tissue response to rituximab: mechanism of action and identification of biomarkers of response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-013-0185-9

Induction of long-term B-cell depletion in refractory rheumatoid arthritis patients preferentially affects autoreactive more than protective humoral immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-013-0185-9

Mechanisms that determine plasma cell lifespan and the duration of humoral immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-013-0185-9

Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-013-0185-9

Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis

21 January 2018

1 reference

12 December 2020

Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20.

1 reference

12 December 2020

New biomarkers in rheumatoid arthritis

1 reference

12 December 2020

Hemoglobin carbamylation in uremia

1 reference

12 December 2020

Revised criteria for the classification of rheumatoid arthritis

1 reference

12 December 2020

Targeting interleukin-17 in patients with active rheumatoid arthritis: rationale and clinical potential

1 reference

12 December 2020

Baseline anti-citrullinated peptide antibody (ACPA) titers and serum interleukin-6 (IL-6) levels possibly predict progression of bone destruction in early stages of rheumatoid arthritis (ERA)

1 reference

12 December 2020

10.1007/S11914-013-0185-9

Identifiers

DOI

1 reference

Dimensions Publication ID

30 August 2017

1039586762

0 references

1 reference